Turn All Business Travel Into a Holiday
with a Team That Understands
What You Need
Upcoming Trade Shows in for Medical & Pharma
BIO-EUROPE 2024, Munich, Germany
4 - 6 Nov 2024
MEDICA 2024, Düsseldorf, Germany
11 - 14 Nov 2024
CPhI Middle East 2024, Riyadh, Saudi Arabia
10 - 12 Dec 2024
Pharmapack Europe 2025, Paris, France
22 - 23 Jan 2025
Arab Health 2025, Dubai, UAE
27 - 30 Jan 2025
PharmagoraPlus 2025, Paris, France
8 - 9 Mar 2025
IDS 2025, Köln, Germany
25 - 29 Mar 2025
ALTENPFLEGE 2025, Nurnberg, Germany
8 - 10 Apr 2025
Cosmofarma 2025, Bologna, Italy
11 - 13 Apr 2025
INTERNATIONAL EXPODENTAL 2025, Rimini, Italy
15 - 17 May 2025
Hospitalar 2025, São Paulo, Brazil
20 - 23 May 2025
CPhI China 2025, Shanghai, China
24 - 26 Jun 2025
ESC Congress 2025, Madrid, Spain
29 Aug - 1 Sep 2025
Expopharm 2025, Düsseldorf, Germany
16 - 18 Sep 2025
CPhI Worldwide 2025, Frankfurt am Main, Germany
28 - 30 Oct 2025
The medical and pharmaceutical industry has entered a new era of advances in technology and economic pressures. One of the most notable shifts in healthcare delivery is the migration of services from traditional acute care settings to ambulatory, home, and virtual environments. This trend, propelled by the need for cost control and value-based reimbursement models, is reshaping how healthcare is provided and consumed. As healthcare services become more decentralized, stakeholders are responding with strategic investments, mergers, and acquisitions (M&A) to adapt to changing utilization patterns. The rise of consumer-driven technology and data advancements is also playing a crucial role, as patients increasingly demand more personalized and accessible care. These factors place the healthcare and life sciences sectors at a critical juncture as we move further into 2024, with economic, technological, and political influences creating a complex landscape for industry players.
One of the most significant developments in recent years has been the growing presence of private equity (PE) in the healthcare sector. Over the past decade, annual deal values in this space have skyrocketed, from $41.5 billion in 2010 to nearly $120 billion by 2019. This rapid increase has attracted scrutiny from lawmakers and researchers, raising concerns about the potential impact on pricing, competition, and the quality of care in private equity-backed organizations. Given these concerns, it is crucial for private equity firms to focus on strategic areas that will help maintain the quality of care while mitigating regulatory and compliance risks. Key areas of focus include сnvesting in staffing and training. It’s essential to ensure that healthcare facilities are adequately staffed and that continuous training programs are in place. This helps maintain high standards of care and reduces the risk of adverse outcomes such as patient falls and infections.
GET A FREE QUOTE
Looking for a hotel accommodation for particular trade show or exhibition.
Send us a general enquiry and we will find the best options for you
Send us a general enquiry and we will find the best options for you